Faculty Opinions recommendation of Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remission.

Haematopoietic cell transplantation with and without sorafenib maintenance for patients withFLT3-ITD acute myeloid leukaemia in first complete remission

10.1111/bjh.14260 ◽

2016 ◽

Vol 175 (3) ◽

pp. 496-504 ◽

Cited By ~ 99

Author(s):

Andrew M. Brunner ◽

Shuli Li ◽

Amir T. Fathi ◽

Martha Wadleigh ◽

Vincent T. Ho ◽

...

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Haematopoietic Cell ◽

Faculty Opinions recommendation of Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958906.793462914 ◽

2012 ◽

Author(s):

Nelson Chao

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Reduced Intensity Conditioning ◽

Open Label ◽

Phase 3 ◽

Reduced Intensity ◽

Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(12)70349-2 ◽

2012 ◽

Vol 13 (10) ◽

pp. 1035-1044 ◽

Cited By ~ 144

Author(s):

Martin Bornhäuser ◽

Joachim Kienast ◽

Rudolf Trenschel ◽

Andreas Burchert ◽

Ute Hegenbart ◽

...

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Reduced Intensity Conditioning ◽

Open Label ◽

Phase 3 ◽

Reduced Intensity ◽

Faculty Opinions recommendation of Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958906.793464270 ◽

2012 ◽

Author(s):

Anskar YH Leung

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Reduced Intensity Conditioning ◽

Open Label ◽

Phase 3 ◽

Reduced Intensity ◽

Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission

Leukemia ◽

10.1038/leu.2008.352 ◽

2009 ◽

Vol 23 (4) ◽

pp. 635-640 ◽

Cited By ~ 57

Author(s):

N Basara ◽

◽

A Schulze ◽

U Wedding ◽

M Mohren ◽

...

Keyword(s):

Overall Survival ◽

High Risk ◽

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Conventional Chemotherapy ◽

Free Survival ◽

Haematopoietic Cell ◽

Incidence and reasons for late failure after allogeneic haematopoietic cell transplantation following BuCy2 in acute myeloid leukaemia

10.1111/j.1365-2141.2009.07947.x ◽

2010 ◽

Vol 148 (4) ◽

pp. 623-626 ◽

Cited By ~ 2

Author(s):

Shubham Pant ◽

Mehdi Hamadani ◽

Anthony J. Dodds ◽

Jeffrey Szer ◽

Pamela A. Crilley ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Haematopoietic Cell ◽

Late Failure ◽

Allogeneic Haematopoietic Cell Transplantation ◽

Second allogeneic haematopoietic cell transplantation using HLA‐matched unrelated versus T‐cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia

10.1111/bjh.17426 ◽

2021 ◽

Author(s):

Mohamed A. Kharfan‐Dabaja ◽

Myriam Labopin ◽

Eolia Brissot ◽

Nicolaus Kroger ◽

Jürgen Finke ◽

...

Keyword(s):

T Cell ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Haematopoietic Cell ◽

Allogeneic Haematopoietic Cell Transplantation ◽

The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia.

10.1111/j.1365-2141.2006.06476.x ◽

2007 ◽

Vol 136 (4) ◽

pp. 624-627 ◽

Cited By ~ 164

Author(s):

Francis J. Giles ◽

Gautam Borthakur ◽

Farhad Ravandi ◽

Stefan Faderl ◽

Srdan Verstovsek ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Induction Therapy ◽

Early Death ◽

Index Score ◽

Haematopoietic Cell ◽

Comorbidity Index ◽

Monitoring of post-transplantCBFB-MYH11as minimal residual disease, rather thanKITmutations, can predict relapse after allogeneic haematopoietic cell transplantation in adults with inv(16) acute myeloid leukaemia

10.1111/bjh.14340 ◽

2016 ◽

Vol 180 (3) ◽

pp. 448-451 ◽

Cited By ~ 11

Author(s):

Fei-Fei Tang ◽

Lan-Ping Xu ◽

Xiao-Hui Zhang ◽

Huan Chen ◽

Yu-Hong Chen ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Minimal Residual Disease ◽

Cell Transplantation ◽

Residual Disease ◽

Haematopoietic Cell ◽

Allogeneic Haematopoietic Cell Transplantation ◽

Minimal Residual ◽

Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission

10.1002/14651858.cd010248 ◽

2012 ◽

Cited By ~ 1

Author(s):

Chen Mao ◽

Ya-Fang Huang ◽

Zu-Yao Yang ◽

Qian-Ling YE ◽

Xin-Yin Wu ◽

...

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Maintenance Therapy ◽

Myeloid Leukaemia ◽

Interleukin 2 ◽